Bile acid and immunosuppressive therapy in primary biliary cirrhosis
(De behandeling van primaire biliaire cirrose met galzuren en immunsuppressie)
1995-09-20
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(950920_WOLFHAGEN, Franciscus Hubertus Joseph.pdf, 3.6MB) |
|
View PDF Version
(stellingen Wolfhagen.pdf, 0.0MB) |
Primary Biliary Cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by non-suppurative destruction of interlobular and septal bile ducts, with subsequent liver damage and eventually development of cirrhosis. The disease is relatively rare with an estimated annual incidence and point prevalence in Europe of about 14 and 114 per million population respectively.The course of the disease is variable and unpredictable, but potentially fa1tal.
Supervisors
(promotores):
The
author
wishes to thank:
Zambon Nederland BV
Keywords
Automatically Extracted Terms
- patient
- biliary cirrhosis
- biliary
- cirrhosis
- treatment
- disease
- liver
- study
- effect
- group
- ursodeoxycholic acid
- trial
- ursodeoxycholic
- therapy
- prednisone
- stage
- month
- gastroenterology
- bilirubin
- level
